UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiparametric Photoacoustic Analysis of Human Thyroid Cancers In Vivo

Cancer research (Chicago, Ill.), 2021-09, Vol.81 (18), p.4849-4860

2021

Volltextzugriff (PDF)

A Novel MLL5 Isoform That Is Essential to Activate E6 and E7 Transcription in HPV16/18-Associated Cervical Cancers

Cancer research (Chicago, Ill.), 2011-11, Vol.71 (21), p.6696-6707

2011

Volltextzugriff (PDF)

Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway

Cancer research (Chicago, Ill.), 2021-01, Vol.81 (2), p.464-475

2021

Volltextzugriff (PDF)

Abstract P5-06-06: Clinically significant changes of receptors status (ER, PR and HER2) after receiving neoadjuvant chemotherapy (NACT) in breast cancer (BC) predicts the prognosis and guides the choice of the optimal adjuvant therapy (AT): Retesting of the receptor status should be mandatory

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-06-06

2020

Volltextzugriff (PDF)

Abstract P3-07-02: Developing a robust multidimensional molecular, pathological and radiological prognostic index (MPRPI) to evaluate the response to neoadjuvant chemotherapy (NACT) and predict clinical outcome of breast cancer (BC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-07-02

2020

Volltextzugriff (PDF)

Abstract 3747: Bronchial washing fluid sequencing is useful in the diagnosis of lung cancer with necrotic tumor

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.3747-3747

2024

Volltextzugriff (PDF)

Abstract 3990: Tri-compartment (epithelial, immune, fibroblast) patient-derived models of the tumor microenvironment from an immuno-genomic profiled cohort of early stage colorectal cancers

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3990-3990

2020

Volltextzugriff (PDF)

Abstract 4697: Quantitation of BRAF V600E alleles predicts papillary thyroid cancer progression

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4697-4697

2014

Volltextzugriff (PDF)

Abstract 5132: The immunomodulatory role of paracrine signaling factor VSIG4 in peritoneal cancers

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5132-5132

2023

Volltextzugriff (PDF)

MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1

Cancer research (Chicago, Ill.), 2015-04, Vol.75 (7), p.1298-1310

2015

Volltextzugriff (PDF)

Abstract 2009: Gemcitabine-loaded EGFR aptamer for targeted therapy of lung cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2009-2009

2023

Volltextzugriff (PDF)

Abstract 419: Single cell-driven secreted proteins as a surrogate biomarker for Cetuximab therapy in colorectal cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.419-419

2019

Volltextzugriff (PDF)

Abstract 4114: Development and application of 18F-labeled Tenascin-C aptamer for cancer imaging

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4114-4114

2018

Volltextzugriff (PDF)

Abstract 1800: Noninvasive approach to assess metastatic lesion of advanced colorectal cancer by denoised deep target sequencing

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1800-1800

2017

Volltextzugriff (PDF)

Circulating small extracellular vesicles activate TYRO3 to drive cancer metastasis and chemoresistance

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13), p.3539-3553

2021

Volltextzugriff (PDF)

Abstract 4379: RING1, a novel E3 ubiquitin ligase for CIP2A, negatively regulates smoking-induced lung tumorigenesis

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4379-4379

2024

Volltextzugriff (PDF)

Abstract 4849: YPN-005, an oral CDK7 inhibitor, shows a significant antitumor activity in Myc amplified solid tumors and MCL-1 overexpressed blood cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4849-4849

2020

Volltextzugriff (PDF)

Abstract 5214: Activation of WNT/b-catenin signaling results in resistance to PI3K/mTOR dual inhibitor in co-existing KRAS and PIK3CA mutant colorectal cancer cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5214-5214

2017

Volltextzugriff (PDF)

Abstract 3167: MIF-induced stat3 activation promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3167-3167

2017

Volltextzugriff (PDF)

Abstract 899: Development of a deep learning model for cell type mapping in colorectal cancer using H&E images leveraging image-based spatial transcriptomics data

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.899-899

2024

Volltextzugriff (PDF)

Abstract 4948: Automated tumor microenvironment analysis for multiple samples by image-based spatial transcriptomics on tissue microarray

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4948-4948

2024

Volltextzugriff (PDF)

Abstract 3481: Comparative spatial transcriptomic analysis of monoclonal antibodies targeting the same molecule: A comparison between cetuximab and panitumumab

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.3481-3481

2024

Volltextzugriff (PDF)

Abstract P1-19-03: Phase II trial of durvalumab and tremelimumab in the hormone receptor-positive metastatic breast cancer with high tumor mutational burden selected by whole exome sequencing: Korean cancer study group trial (KCSG BR17-04)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-19-03

2022

Volltextzugriff (PDF)

Abstract CT117: A phase 1 study of D3S-001, a second-generation GDP-bound KRAS G12C inhibitor, as monotherapy in patients with KRAS G12C-mutated solid tumors

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT117-CT117

2024

Volltextzugriff (PDF)

Abstract P4-04-06: Urine microbiome and breast cancer: The relationship with hormone therapies

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P4-P4-04-06

2020

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(90)

Sprache

Englisch
(90)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Multiparametric Photoacoustic Analysis of Human Thyroid Cancers In Vivo

A Novel MLL5 Isoform That Is Essential to Activate E6 and E7 Transcription in HPV16/18-Associated Cervical Cancers

Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway

Abstract P5-06-06: Clinically significant changes of receptors status (ER, PR and HER2) after receiving neoadjuvant chemotherapy (NACT) in breast cancer (BC) predicts the prognosis and guides the choice of the optimal adjuvant therapy (AT): Retesting of the receptor status should be mandatory

Abstract P3-07-02: Developing a robust multidimensional molecular, pathological and radiological prognostic index (MPRPI) to evaluate the response to neoadjuvant chemotherapy (NACT) and predict clinical outcome of breast cancer (BC)

Abstract 3747: Bronchial washing fluid sequencing is useful in the diagnosis of lung cancer with necrotic tumor

Abstract 3990: Tri-compartment (epithelial, immune, fibroblast) patient-derived models of the tumor microenvironment from an immuno-genomic profiled cohort of early stage colorectal cancers

Abstract 4697: Quantitation of BRAF V600E alleles predicts papillary thyroid cancer progression

Abstract 5132: The immunomodulatory role of paracrine signaling factor VSIG4 in peritoneal cancers

MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1

Abstract 2009: Gemcitabine-loaded EGFR aptamer for targeted therapy of lung cancer

Abstract 419: Single cell-driven secreted proteins as a surrogate biomarker for Cetuximab therapy in colorectal cancer

Abstract 4114: Development and application of 18F-labeled Tenascin-C aptamer for cancer imaging

Abstract 1800: Noninvasive approach to assess metastatic lesion of advanced colorectal cancer by denoised deep target sequencing

Circulating small extracellular vesicles activate TYRO3 to drive cancer metastasis and chemoresistance

Abstract 4379: RING1, a novel E3 ubiquitin ligase for CIP2A, negatively regulates smoking-induced lung tumorigenesis

Abstract 4849: YPN-005, an oral CDK7 inhibitor, shows a significant antitumor activity in Myc amplified solid tumors and MCL-1 overexpressed blood cancer

Abstract 5214: Activation of WNT/b-catenin signaling results in resistance to PI3K/mTOR dual inhibitor in co-existing KRAS and PIK3CA mutant colorectal cancer cells

Abstract 3167: MIF-induced stat3 activation promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells

Abstract 899: Development of a deep learning model for cell type mapping in colorectal cancer using H&E images leveraging image-based spatial transcriptomics data

Abstract 4948: Automated tumor microenvironment analysis for multiple samples by image-based spatial transcriptomics on tissue microarray

Abstract 3481: Comparative spatial transcriptomic analysis of monoclonal antibodies targeting the same molecule: A comparison between cetuximab and panitumumab

Abstract P1-19-03: Phase II trial of durvalumab and tremelimumab in the hormone receptor-positive metastatic breast cancer with high tumor mutational burden selected by whole exome sequencing: Korean cancer study group trial (KCSG BR17-04)

Abstract CT117: A phase 1 study of D3S-001, a second-generation GDP-bound KRAS G12C inhibitor, as monotherapy in patients with KRAS G12C-mutated solid tumors

Abstract P4-04-06: Urine microbiome and breast cancer: The relationship with hormone therapies

Aktive Filter

Suchergebnisse filtern